🇺🇸 Indium-DTPA in United States

FDA authorised Indium-DTPA on 18 February 1982

Marketing authorisations

FDA — authorised 18 February 1982

  • Application: NDA017707
  • Marketing authorisation holder: GE HEALTHCARE
  • Status: supplemented

FDA

  • Status: approved

Indium-DTPA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Indium-DTPA approved in United States?

Yes. FDA authorised it on 18 February 1982; FDA has authorised it.

Who is the marketing authorisation holder for Indium-DTPA in United States?

GE HEALTHCARE holds the US marketing authorisation.